Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$36.71 - $44.15 $4.52 Million - $5.44 Million
123,198 Added 52.81%
356,499 $14.8 Million
Q1 2023

May 12, 2023

BUY
$36.81 - $48.12 $4.48 Million - $5.85 Million
121,650 Added 108.96%
233,301 $9.64 Million
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $93,680 - $119,500
-2,000 Reduced 1.76%
111,651 $5.49 Million
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $117,975 - $156,700
-2,500 Reduced 2.15%
113,651 $5.96 Million
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $426,825 - $508,575
-7,500 Reduced 6.07%
116,151 $6.95 Million
Q2 2021

Aug 13, 2021

SELL
$64.02 - $71.72 $108,834 - $121,924
-1,700 Reduced 1.36%
123,651 $8.38 Million
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $34,565 - $44,183
-649 Reduced 0.52%
125,351 $8.22 Million
Q4 2020

Feb 05, 2021

SELL
$43.41 - $56.51 $125,888 - $163,879
-2,900 Reduced 2.25%
126,000 $7.1 Million
Q3 2020

Nov 06, 2020

BUY
$47.43 - $60.75 $42,687 - $54,675
900 Added 0.7%
128,900 $6.26 Million
Q2 2020

Aug 13, 2020

SELL
$43.51 - $66.59 $326,325 - $499,425
-7,500 Reduced 5.54%
128,000 $7.12 Million
Q1 2020

May 14, 2020

SELL
$32.82 - $81.13 $98,460 - $243,390
-3,000 Reduced 2.17%
135,500 $6.86 Million
Q4 2019

Feb 14, 2020

SELL
$60.96 - $77.7 $816,864 - $1.04 Million
-13,400 Reduced 8.82%
138,500 $10.7 Million
Q3 2019

Nov 01, 2019

SELL
$55.78 - $68.08 $139,450 - $170,200
-2,500 Reduced 1.62%
151,900 $9.63 Million
Q2 2019

Aug 02, 2019

SELL
$53.69 - $65.47 $703,339 - $857,657
-13,100 Reduced 7.82%
154,400 $9.04 Million
Q1 2019

May 02, 2019

BUY
$44.53 - $58.9 $66,795 - $88,350
1,500 Added 0.9%
167,500 $9.51 Million
Q4 2018

Jan 30, 2019

SELL
$47.64 - $71.26 $47,640 - $71,260
-1,000 Reduced 0.6%
166,000 $8.23 Million
Q3 2018

Nov 02, 2018

SELL
$52.03 - $71.41 $2.73 Million - $3.75 Million
-52,500 Reduced 23.92%
167,000 $11.9 Million
Q2 2018

Aug 10, 2018

SELL
$48.15 - $56.68 $2.76 Million - $3.25 Million
-57,311 Reduced 20.7%
219,500 $11.4 Million
Q1 2018

May 09, 2018

SELL
$46.03 - $61.28 $3.84 Million - $5.11 Million
-83,452 Reduced 23.16%
276,811 $14.5 Million
Q4 2017

Feb 02, 2018

SELL
$50.58 - $60.79 $568,367 - $683,097
-11,237 Reduced 3.02%
360,263 $21.1 Million
Q3 2017

Nov 01, 2017

BUY
$53.54 - $68.0 $19.9 Million - $25.3 Million
371,500
371,500 $20.6 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.